Effect of pinggan jiangya capsule on plasma endothelins and angiotensin Ⅱ in patients with primary hypertension

杜立峰,杨杰,孙师元,王小闯,吴喜利
DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.36.056
2004-01-01
Abstract:Aim: To observe the relationship among the change of blood pressure, plasma endothelins and angiotensin II (Ang II) in patients with primary hypertension during the treatment with pinggan jiangya capsule, so as to investigate the therapeutic effect and the mechanism. Methods: A total of 160 patients with primary hypertension, selected from the Department of Emergency, Integrated Traditional Chinese Medicine and Western Medicine, and out-patient clinic, the Second Hospital, Xi'an Jiaotong University from November 2002 to May 2004, were randomly and double-blindly divided into treatment group and control group treated by pinggan jiangya capsule and qingnao jiangya pian, respectively, with 80 patients in each group. All patients were treated for 12 weeks in order to observe the changes of clinical symptoms, blood pressure, hemorheology, plasma endothelins and Ang II before and after treatment. Results: Pinggan jiangya capsule could decrease the blood pressure and improve the clinical symptoms, and also decrease the blood hypercoagulability and the level of plasma endothelins [(72.22 ± 12.37) vs (59.08 ± 12.77)ng/L] and Ang II[(84.75 ± 7.34) vs (61.37 ± 8.31)ng/L] obviously (P < 0.05 or P < 0.01). Conclution: Pinggan jiangya capsule can improve the blood hypercoagulability according to the decreasing of the level of plasma endothelins and Ang II, so as to decrease the blood pressure.
What problem does this paper attempt to address?